Publications by authors named "Thanus Pienthong"
Background: A risk categorization tool for healthcare workers (HCWs) exposed to COVID-19 is crucial for preventing COVID-19 transmission and requires validation and modification according to local context.
Methods: From January to December 2021, a prospective cohort study was conducted among Thai HCWs to evaluate the performance of the specifically-created risk categorization tool, which classified HCWs into low-risk (LR), intermediate-risk (IR), and high-risk (HR) groups based on types of activities, duration of exposure, and protective methods used during exposure. Subsequent measures were determined for the HCWs based on the risk categories.
Increase in the incidence of and bloodstream infections during the coronavirus disease 2019 (COVID-19) pandemic.
Antimicrob Steward Healthc Epidemiol
January 2023
An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care Favipiravir-Based Standard of Care for Treatment of Moderate COVID-19 in Thailand.
Infect Chemother
March 2023
Background: The role of ivermectin in the treatment of moderate coronavirus disease 2019 (COVID-19) is controversial. We performed an open label randomized controlled trial to evaluate the role of ivermectin plus favipiravir-based standard of care versus favipiravir-based standard of care for the treatment of moderate COVID-19 infection.
Materials And Methods: An open-label randomized control trial was performed at Thammasat Field Hospital and Thammasat University Hospital from October 1st, 2021 to May 31st, 2022.
Feasibility and safety of reducing duration of quarantine for healthcare personnel with high-risk exposures to coronavirus disease 2019 (COVID-19): From alpha to omicron.
Infect Control Hosp Epidemiol
January 2023
Factors associated with coronavirus disease 2019 (COVID-19) among Thai healthcare personnel with high-risk exposures: The important roles of double masking and physical distancing while eating.
Infect Control Hosp Epidemiol
December 2022